Skip to main content

Table 1

From: Absence of autoantibodies connected to autoimmune polyendocrine syndrome type I and II and Addison's disease in girls and women with Turner syndrome

Disease

Antigen

Enzyme action

Addison's disease

21-Hydroxylase (21-OH)

Steroid hormone synthesis

Addison's disease with POF

21-Hydroxylase (21-OH)

Steroid hormone synthesis

 

Side-chain cleavage enzyme (SCC)

Steroid hormone synthesis

APS I

17α-hydroxylase (17α-OH)

Steroid hormone synthesis

 

Aromatic L-amino acid decarboxylase (AADC)

Monoaminergic and serotonergic biosynthetic pathways

 

Tyrosine hydroxylase (TH)

Rate-limiting enzyme in catecholamine biosynthesis

 

Tryptophan hydroxylase (TPH)

Rate limiting enzyme in the synthesis of serotonin

APS II

21-Hydroxylase (21-OH)

Steroid hormone synthesis

  1. Description of important autoantigens in Addison's disease, Addison's disease with premature ovarian failure (POF), APS I and APS II. Patients with Addison's disease generally display autoantibodies to the enzyme 21-OH restricted to the adrenal cortex, while most of the patients with APS I show autoantibodies to SCC, located both in the adrenal cortex and steroid producing cells in the gonads, reflecting the risk of developing ovarian failure. In addition patients with Addison's disease and POF, also show antibodies directed against SCC (13). TPH is found as an intestinal autoantigen in APS I patients with intestinal dysfunction (14) and TH autoantibodies are correlated to alopecia areata in these patients (15).